We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRN icon
2026
Citi Trends
CTRN
$605M
$4.76M ﹤0.01%
205,896
-47,667
-19% -$929K
INGN icon
2027
Inogen
INGN
$164M
$4.75M ﹤0.01%
69,584
-1,825
-3% -$114K
CAC icon
2028
Camden National
CAC
$976M
$4.74M ﹤0.01%
103,002
+9
+0% +$397
UGP icon
2029
Ultrapar
UGP
$6.54B
$4.74M ﹤0.01%
757,189
+2,069
+0.3% +$10.5K
JOUT icon
2030
Johnson Outdoors
JOUT
$505M
$4.74M ﹤0.01%
61,745
+18,045
+41% +$1.18M
PINC
2031
DELISTED
Premier
PINC
$4.73M ﹤0.01%
124,974
-7,902
-6% -$278K
FLXN
2032
DELISTED
Flexion Therapeutics, Inc.
FLXN
$4.73M ﹤0.01%
228,604
+45,792
+25% +$772K
NHC icon
2033
National Healthcare
NHC
$3.38B
$4.7M ﹤0.01%
54,346
-398
-0.7% -$33.3K
NXTC icon
2034
NextCure
NXTC
$26.7M
$4.66M ﹤0.01%
6,898
+3,210
+87% +$1.61M
MYE icon
2035
Myers Industries
MYE
$1.29B
$4.66M ﹤0.01%
279,203
+142,435
+104% +$2.37M
URBN icon
2036
Urban Outfitters
URBN
$6.59B
$4.65M ﹤0.01%
167,444
-14,193
-8% -$395K
ACCO icon
2037
Acco Brands
ACCO
$407M
$4.63M ﹤0.01%
494,611
-6,662
-1% -$63.1K
BRSP
2038
BrightSpire Capital
BRSP
$648M
$4.6M ﹤0.01%
349,303
+1,097
+0.3% +$14.9K
ADUS icon
2039
Addus HomeCare
ADUS
$2.23B
$4.54M ﹤0.01%
46,659
+1,351
+3% +$119K
LNN icon
2040
Lindsay Corp
LNN
$1.18B
$4.53M ﹤0.01%
47,203
-816
-2% -$74.6K
OIS icon
2041
Oil States International
OIS
$491M
$4.53M ﹤0.01%
277,764
-154,360
-36% -$2.34M
NUS icon
2042
Nu Skin
NUS
$267M
$4.52M ﹤0.01%
110,290
-90,537
-45% -$3.69M
NVEC icon
2043
NVE Corp
NVEC
$609M
$4.52M ﹤0.01%
63,269
+16,908
+36% +$1.1M
OSPN icon
2044
OneSpan
OSPN
$618M
$4.51M ﹤0.01%
263,692
+37,871
+17% +$644K
ANF icon
2045
Abercrombie & Fitch
ANF
$5B
$4.5M ﹤0.01%
260,418
-12,885
-5% -$213K
RLGT icon
2046
Radiant Logistics
RLGT
$395M
$4.5M ﹤0.01%
806,863
+3,381
+0.4% +$18.3K
BVH
2047
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$4.49M ﹤0.01%
188,295
+31,313
+20% +$721K
SFIX
2048
Stitch Fix
SFIX
$560M
$4.47M ﹤0.01%
174,282
+3,898
+2% +$90.6K
CVI icon
2049
CVR Energy
CVI
$3.13B
$4.47M ﹤0.01%
110,466
-168,892
-60% -$7.42M
FSP
2050
Franklin Street Properties
FSP
$46.8M
$4.46M ﹤0.01%
521,167
-8,681
-2% -$74.7K

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.